Last checked at 
17 Aug 2022 12:00
LEI: 549300Q7EXQQH6KF7Z84
17 August 2022
RTW Venture Fund Limited
Notice of Interim Report
RTW Venture Fund Limited (the "Company") advises that it will publish its Interim Report for the six months ended 30 June 2022 (the "Interim Report") on 15 September 2022.
A conference call for analysts and shareholders will be held at 2 pm BST / 9 am EST on the day. To register for the event please RSVP to georgeb@buchanan.uk.com or IR@rtwfunds.com.
For Further Information
RTW Investments, LP +44 (0)771 741 7711 Stephanie Sirota, Chief Business OfficerWoody Stileman, Managing Director, Strategic Partnerships
Buchanan +44 (0)20 7466 5000 Charles Ryland
Henry Wilson
George Beale
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.